Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Gesundheitswesen ; 79(2): 89-95, 2017 Feb.
Article in German | MEDLINE | ID: mdl-26551852

ABSTRACT

Objective: Evaluation of a project offering low-threshold anonymous counseling services jointly by mental health services and child and youth services to support children in families with mentally ill parents Methods: Evaluating performance data and completed questionnaires returned by parents included in the project. Results: Between 2011-2014, 150 families received up to 10 sessions of family-oriented counseling. The survey results indicate a high level of satisfaction with the services of the cooperation project. The vast majority of respondents said that they would recommend this service to others or would themselves take advantage of the services again. Conclusion: A collaboration of service providers from psychiatry and child and youth welfare department resulting in continuous availability of counseling with a common family medical perspective represents a forward-looking model for families with a mentally ill parent.


Subject(s)
Child Welfare/statistics & numerical data , Child of Impaired Parents/statistics & numerical data , Family Therapy/organization & administration , Mental Disorders/therapy , Mental Health Services/organization & administration , Patient Care Team/statistics & numerical data , Patient Satisfaction/statistics & numerical data , Adolescent , Adult , Child , Child Welfare/psychology , Child of Impaired Parents/psychology , Child, Preschool , Directive Counseling/statistics & numerical data , Female , Germany/epidemiology , Humans , Infant , Infant, Newborn , Intersectoral Collaboration , Male , Mental Disorders/epidemiology , Mental Disorders/psychology , Mentally Ill Persons/psychology , Middle Aged , Social Support , Vulnerable Populations/psychology , Young Adult
2.
J Endocrinol ; 204(2): 153-64, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19939912

ABSTRACT

Obesity is associated with chronic inflammation. Pro-inflammatory adipokines may promote metabolic disorders and cardiovascular morbidity. However, the key mechanisms leading to obesity-related inflammation are poorly understood. The corticosteroid metabolism in adipose tissue plays a crucial role in the pathogenesis of the metabolic syndrome. Both the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR) mediate corticosteroid action in adipose tissue. The significance of the interplay of these receptors in mediating an inflammatory adipokine response is virtually unexplored. In the present study, we investigated the differential roles of the GR and MR in controlling the key adipose tissue functions including inflammatory adipokine expression and adipogenesis using selective stimulation with receptor agonists, acute receptor knockdown via RNA interference and newly generated knockout adipose cell lines. Selective GR stimulation of white adipocytes with dexamethasone inhibited the expression of interleukin 6 (IL6), monocyte chemoattractant protein-1 (MCP1 or CCL2 as listed in the MGI Database), tumour necrosis factor-alpha, chemerin and leptin. By contrast, selective MR stimulation with aldosterone promoted the expression of IL6, plasminogen activator inhibitor 1, chemerin and leptin. Furthermore, in the presence of an acute GR knockdown as well as in GR knockout adipocytes, corticosterone increased the gene expression of the pro-inflammatory adipokines IL6 and MCP1. Whereas GR knockout adipocytes displayed a mildly impaired adipogenesis during early differentiation, MR knockout cells completely failed to accumulate lipids. Taken together, our data demonstrate a critical role for the balance between gluco- and mineralocorticoid action in determining adipocyte responses implicated in obesity-associated inflammation and cardiovascular complications.


Subject(s)
Adipocytes/metabolism , Adipokines/metabolism , Inflammation/metabolism , Receptors, Glucocorticoid/metabolism , Receptors, Mineralocorticoid/metabolism , Adipocytes/cytology , Aldosterone , Animals , Anti-Inflammatory Agents , Cell Differentiation , Cell Line , Chemokine CCL2/metabolism , Corticosterone , Dexamethasone , Interleukin-6/metabolism , Lipid Metabolism , Mice , Mice, Knockout , Up-Regulation
3.
Eur J Pharmacol ; 392(1-2): 93-9, 2000 Mar 24.
Article in English | MEDLINE | ID: mdl-10748277

ABSTRACT

The study was performed to investigate effects of the phosphodiesterase 4 inhibitor RPR 73401 [N-(3, 5-dichloropyrid-4-yl)-3-cyclopentyl-oxy-4-methoxybenzamid] on an allergic skin reaction. To simulate an immunological inflammation, BALB/c mice were sensitized to dinitrochlorobenzene or toluenediisocyanate. At first, the abdominal skin was shaved and 50 microliter Freund's adjuvant were injected intracutaneously once. Then, the horny layer was removed by adhesive tape stripping and 100 microliter 0.5% dinitrochlorobenzene or 5% toluenediisocyanate were administered on the epidermis for 4 days. After repeated local treatment of the ear skin with 20 microliter 3% RPR 73401 or intraperitoneal administration of 1 and 5 mg/kg RPR 73401, 20 microliter 1% dinitrochlorobenzene or 0.5% toluenediisocyanate were given topically as a challenge. The vehicle controls showed a high increase in ear thickness over 48 h after challenge, whereas RPR 73401 administered on either route reduced this increase significantly. Nevertheless after topical administration, RPR 73401 had a longer lasting effect. These and other results may point to an indication for RPR 73401 in immunological dermatitis.


Subject(s)
Benzamides/therapeutic use , Dermatitis, Allergic Contact/drug therapy , Phosphodiesterase Inhibitors/therapeutic use , Pyridines/therapeutic use , Administration, Topical , Animals , Cyclosporine/therapeutic use , Dinitrobenzenes , Disease Models, Animal , Female , Interleukin-4/analysis , Mice , Mice, Inbred BALB C , Toluene 2,4-Diisocyanate
4.
Hepatology ; 14(2): 373-80, 1991 Aug.
Article in English | MEDLINE | ID: mdl-1860695

ABSTRACT

In mammalian cells, nucleoside transport usually is mediated by facilitated diffusion. In addition, a Na(+)-dependent, concentrative nucleoside transport system has been detected in several tissues but not the liver. To further clarify hepatic nucleoside transport mechanisms, we measured the uptake of [2-14C]uridine (2 to 100 mumol/L) and of [8-14C]adenosine (10 to 75 mumol/L) by the isolated perfused rat liver in the presence or absence of extracellular sodium or specific inhibitors of facilitated nucleoside diffusion. Uridine transport and metabolism were monitored by the release of labeled catabolites including 14CO2, which indicated complete degradation of the pyrimidine. Adenosine, uridine and uridine catabolites were measured in the effluent perfusate by reversed-phase high-performance liquid chromatography and a radioactivity flow monitor. The existence of a Na(+)-dependent nucleoside transport system could be inferred from the following observations: (a) Sodium depletion caused a strong inhibition of nucleoside transport reflected by an up to threefold and 15-fold increase in extracellular uridine and adenosine, respectively. The sodium-dependent transport of uridine was saturated when the influent uridine concentration was raised beyond 20 mumol/L. No such saturation was observed for much higher concentrations of adenosine used (10 to 75 mumol/L). (b) Na(+)-free perfusion resulted in a strong suppression of the release of uridine catabolites by the liver. Complete uridine breakdown was depressed to 7% of the amount of 14CO2 released in the presence of sodium and at influent uridine concentrations below 20 mumol/L. (c) Inhibition of uridine (10 mumol/L) transport and degradation was observed after coperfusion with adenosine, deoxyadenosine, guanosine and deoxyguanosine.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Liver/metabolism , Purine Nucleosides/pharmacokinetics , Pyrimidine Nucleosides/pharmacokinetics , Sodium/pharmacology , Animals , Biological Transport/drug effects , Diffusion , Dipyridamole/pharmacology , In Vitro Techniques , Liver/cytology , Male , Nucleosides/antagonists & inhibitors , Perfusion , Rats , Rats, Inbred Strains , Thioinosine/analogs & derivatives , Thioinosine/antagonists & inhibitors , Uridine/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...